Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Fundacion Copec Universidad Católica currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners, which introduces multiple perspectives into the prosecution process. Furthermore, the actions are situated in 2 distinct art units, suggesting that the company's Biotechnology & Pharmaceuticals applications are being reviewed across different specialized divisions of the patent office.
The busiest examiner, BENZION, GARY, is responsible for 1 busiest examiner pending action. Since the total number of pending office actions is 2 and the busiest examiner only holds 1 busiest examiner pending action, the workload is shared between the 2 distinct examiners. For the practitioner, this distribution across 2 distinct art units and 2 distinct examiners means there is no single point of failure in the current portfolio. The strategy for each of the 2 pending office actions can be tailored to the specific norms of their respective art units and the individual tendencies of the assigned examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BENZION, GARY | 1 | 21.1% | +13.7% |
| CAIN, JENNIFER LYNN | 1 | 45.0% | +70.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561157 | IN VITRO CULTURE EXTRACT OF ARISTOTELIA CHILENSIS (MAQUI) WITH ANTIOXIDANT, PROTECTIVE AND SKIN REPAIRING PROPERTIES | CAIN, JENNIFER LYNN | 8d overdue |
| 18563954 | METHOD FOR SIMULTANEOUS DETECTION AND QUANTIFICATION OF Listeria monocytogenes, Salmonella spp., AND SHIGA TOXIN-PRODUCING Escherichia coli (STEC) | BENZION, GARY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561157 | IN VITRO CULTURE EXTRACT OF ARISTOTELIA CHILENSIS (MAQUI) WITH ANTIOXIDANT, PROTECTIVE AND SKIN REPAIRING PROPERTIES | CAIN, JENNIFER LYNN | 8d overdue |
| 18563954 | METHOD FOR SIMULTANEOUS DETECTION AND QUANTIFICATION OF Listeria monocytogenes, Salmonella spp., AND SHIGA TOXIN-PRODUCING Escherichia coli (STEC) | BENZION, GARY | — |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18563954 | METHOD FOR SIMULTANEOUS DETECTION AND QUANTIFICATION OF Listeria monocytogenes, Salmonella spp., AND SHIGA TOXIN-PRODUCING Escherichia coli (STEC) | BENZION, GARY | 1681 | §103§112 | Non-Final OA | — | Pending | Nov 24, 2023 |
| 18561157 | IN VITRO CULTURE EXTRACT OF ARISTOTELIA CHILENSIS (MAQUI) WITH ANTIOXIDANT, PROTECTIVE AND SKIN REPAIRING PROPERTIES | CAIN, JENNIFER LYNN | 1655 | §103§112 | Final Rejection | 8d overdue | Pending | Nov 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial